Regenesis Biomedical, a Scottsdale-based medical device company, has initiated a multi-center, randomized clinical trial assessing the Provant® Therapy System for relieving symptoms of painful diabetic distal symmetric peripheral neuropathy (DSPN). Painful neuropathy affects over 3 million people in the United States, resulting in nerve damage in the extremities such as tingling, numbness, pain and sensitivity … Continue reading Regenesis Biomedical Announces Initiation of a Clinical Trial on Subjects with Painful Diabetic Distal Symmetric Peripheral Neuropathy (DSPN)